Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

RCEL Stock Forecast, Price Targets, Chart, Dividends & Analysis

Avita Medical Inc. logo

Avita Medical Inc.

Sector: Manufacturing   

Industry: Surgical and Medical Instrument Manufacturing

10.34
 
USD
  
-0.23
  
(-2.18%)
Previous close: 10.57  Open: 10.92  Bid: 10.03  Ask: 11.04
52 week range    
7.51   
   18.93
Mkt Cap: 228 M  Avg Vol (90 Days): 198,773
Last updated: Wednesday 19th February 2025
Metrics

Growth

Peers

StockDividendMarket Cap (B)PEPrice ($)
Financials

RCEL Income Statement

Annual
Invalid dateJun-20Jun-21Dec-22Dec-23
AcquisitionExpense6 M
Amortization of intangibles364000.0472000.0465000.0487000.0
Basic EPS from continuing operations-2.07-1.17-1.07-1.4
Basic EPS total-2.07-1.17-1.07-27.93
Basic weighted shares outstanding20 M23 M25 M25 M
Cost of sales3 M6 M6 M8 M
Depletion3 M6 M
Depreciation346000.0606000.0510000.0597000.0
Depreciation unreconciled3 M6 M8 M
DepreciationAndAmortization346000.0606000.0510000.08 M
Diluted EPS total-2.07-1.17-1.07-27.93
Diluted normalized net income/share-2.07-1.17-1.07-1.4
Diluted weighted shares outstanding20 M23 M25 M25 M
GainOnSaleOfPPE-3000.0-83000.0
GeneralAndAdministrativeExpense33 M22 M23 M28 M
Gross operating profit11 M23 M28 M42 M
Income before tax-42 M-27 M-27 M-35 M
Income taxes4000.038000.036000.066000.0
InterestExpenseNonOperating33000.022000.016000.01 M
MiscOtherSpecialCharges686000.017000.0892000.08 M
Net income from total operations-42 M-27 M-27 M-35 M
NetIncomeCommonStockholders-42 M-27 M-27 M-35 M
NetIncomeContinuousOperations-42 M-27 M-27 M-35 M
NetNonOperatingInterestIncomeExpense-33000.0-22000.0-16000.0-1 M
Normalized income-28 M
Operating income-43 M-27 M-28 M-43 M
Operating income before depreciation (EBITDA)-42 M-26 M-26 M-34 M
OperatingExpense58 M52 M56 M85 M
Other income net-686000.0-17000.0892000.08 M
Other special charges-4 M
OtherGandA33 M22 M23 M28 M
OtherOperatingExpenses-4 M-2 M-3 M-1 M
OtherWriteOff43000.09000.0
PromotionAndAdvertising51000.073000.0216000.0398000.0
Research & development expense9 M15 M14 M21 M
ResearchExpense9 M15 M14 M21 M
Revenue per share364000.0601000.0803000.08 M
SalariesAndWages16 M6 M7 M
Selling Gen & administrative expense49 M37 M45 M66 M
SellingAndMarketingExpense16 M15 M22 M37 M
SellingExpense3 M6 M
Special income/charges4 M
Total Income available for interest expense (EBIT)-42 M-27 M-27 M-34 M
Total common shares outstanding21 M25 M25 M26 M
Total net income-42 M-27 M-27 M-35 M
Total ordinary shares26 M26 M26 M26 M
Total revenues14 M29 M34 M50 M
TotalExpenses61 M58 M62 M93 M
TotalRevenue14 M29 M34 M50 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement "your own" investment strategies in Excel with thousands of MarketXLS functions and templates.
MarketXLS provides all the tools I need for in-depth stock analysis. It's user-friendly and constantly improving. A must-have for serious investors.

John D.

Financial Analyst

I have been using MarketXLS for the last 6+ years and they really enhanced the product every year and now in the journey of bringing in AI...

Kirubakaran K.

Investment Professional

MarketXLS is a powerful tool for financial modeling. It integrates seamlessly with Excel and provides real-time data.

David L.

Financial Analyst

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel.

Lloyd L.

Professional Trader